Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
FF-10501-01
i
Other names:
FF-10501-01, FF-10501, FF 10501
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Fujifilm Holdings, Strategia Therap
Drug class:
IMPDH inhibitor, Cell differentiation stimulant
Related drugs:
‹
mizoribine (4)
mizoribine (4)
›
Associations
News
Trials
Filter by
Latest
9ms
Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies (clinicaltrials.gov)
P1/2, N=55, Completed, Fujifilm Pharmaceuticals U.S.A., Inc. | N=41 --> 55
9 months ago
Enrollment change
|
FF-10501-01
over5years
FF-10501 induces caspase-8-mediated apoptotic and endoplasmic reticulum stress-mediated necrotic cell death in hematological malignant cells. (PubMed, Int J Hematol)
FF-10501 induced necrotic cell death via endoplasmic reticulum stress in OCI-AML3 cells. The present study is the first to identify intracellular pathways involved in FF-10501-induced cell death.
over 5 years ago
Journal
|
CASP8 (Caspase 8)
|
FF-10501-01
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.